"Clin Exp Vaccine Res"[Journal] - Search Results

Year	Number of Results
2012	11
2013	37
2014	29
2015	26
2016	24
2017	21
2018	18
2019	18
2020	24
2021	40
2022	39
2023	41
2024	38
2025	48
2026	20

1

Cervical cancer awareness and vaccine hesitancy with respect to HPV vaccination in urban community of Faridabad, Haryana, India.

Jaiswal A, Goyal P, Kumari S, Aggarwal D. Jaiswal A, et al. Clin Exp Vaccine Res. 2026 Jul;15(3):209-215. doi: 10.7774/cevr.2026.15.e20. Epub 2026 Jul 23. Clin Exp Vaccine Res. 2026. PMID: 42565204 Free PMC article.

2

The impact of influenza vaccination on the clinical severity of influenza among children aged 6 months to 6 years living in the community: a prospective cohort study.

Cai X, Zhang A, Luo S, Ma X, Wang B, Meng X, Su Y. Cai X, et al. Clin Exp Vaccine Res. 2026 Jul;15(3):202-208. doi: 10.7774/cevr.2026.15.e19. Epub 2026 Jul 9. Clin Exp Vaccine Res. 2026. PMID: 42565186 Free PMC article.

3

Hepatitis B in the vaccine era: persistent burden and clinical implications.

Nwabueze C, Omeludike E, Lawal R, Nwabueze K. Nwabueze C, et al. Clin Exp Vaccine Res. 2026 Jul;15(3):187-195. doi: 10.7774/cevr.2026.15.e18. Epub 2026 Jun 23. Clin Exp Vaccine Res. 2026. PMID: 42565124 Free PMC article. Review.

4

Microneedle patch technologies in virology: bridging immunization, antiviral therapy, and point-of-care diagnostics.

Mohebbi M, Boogari M, Monavari SH, Hadidi N, Tameshkel FS, Niya MHK. Mohebbi M, et al. Clin Exp Vaccine Res. 2026 Jul;15(3):173-186. doi: 10.7774/cevr.2026.15.e17. Epub 2026 Jun 17. Clin Exp Vaccine Res. 2026. PMID: 42565111 Free PMC article. Review.

5

A prospective study on the safety and clinical effectiveness of rabies monoclonal antibodies for post exposure prophylaxis in suspected rabies exposures at the anti-rabies clinic of KIMS Hospital and Research Centre, Bangalore.

Haradanhalli R, U S, M K P, G DB. Haradanhalli R, et al. Clin Exp Vaccine Res. 2026 Jul;15(3):196-201. doi: 10.7774/cevr.2026.15.e16. Epub 2026 Jun 4. Clin Exp Vaccine Res. 2026. PMID: 42565104 Free PMC article.

6

Determinants of HPV vaccine hesitancy in South Asia: a systematic review.

Malik ZI, Ahmad AMR, Iqbal S. Malik ZI, et al. Clin Exp Vaccine Res. 2026 Apr;15(2):116-137. doi: 10.7774/cevr.2026.15.e12. Epub 2026 Apr 1. Clin Exp Vaccine Res. 2026. PMID: 42099699 Free PMC article. Review.

7

Vaccine development against Mycobacterium tuberculosis: a PRISMA-guided systematic review of conventional and computational multi-epitope approaches.

Akbar EA, Tukiran T, Sanjaya IGM, Agustini R, Sidiq MN. Akbar EA, et al. Clin Exp Vaccine Res. 2026 Apr;15(2):138-150. doi: 10.7774/cevr.2026.15.e15. Epub 2026 Apr 17. Clin Exp Vaccine Res. 2026. PMID: 42099698 Free PMC article. Review.

8

Pharmaceutical design of mRNA vaccines for endemic infectious diseases: integrating antigen discovery with platform engineering.

Hudu SA, Jimoh AO. Hudu SA, et al. Clin Exp Vaccine Res. 2026 Apr;15(2):101-115. doi: 10.7774/cevr.2026.15.e11. Epub 2026 Feb 23. Clin Exp Vaccine Res. 2026. PMID: 42099697 Free PMC article. Review.

9

Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study.

Rathnadiwakara H, Cliquet F, Wasniewski M, Thibault JC, Schereffer JL, Thammitiyagodage M, Ijas M, Samaranayake D, Gunatilake M. Rathnadiwakara H, et al. Clin Exp Vaccine Res. 2026 Apr;15(2):151-166. doi: 10.7774/cevr.2026.15.e13. Epub 2026 Apr 2. Clin Exp Vaccine Res. 2026. PMID: 42099696 Free PMC article.

10

Varicella zoster virus infection and reactivation in a psychiatric ward during the COVID-19 pandemic: a case series analysis.

Huang CC. Huang CC. Clin Exp Vaccine Res. 2026 Apr;15(2):167-172. doi: 10.7774/cevr.2026.15.e14. Epub 2026 Apr 15. Clin Exp Vaccine Res. 2026. PMID: 42099695 Free PMC article.

11

Survival after primary and booster COVID-19 vaccination in patients with COPD.

Karabulut SS, Nemli A, Koçyiğit Y. Karabulut SS, et al. Clin Exp Vaccine Res. 2026 Jan;15(1):57-62. doi: 10.7774/cevr.2026.15.e1. Epub 2025 Sep 24. Clin Exp Vaccine Res. 2026. PMID: 41660222 Free PMC article.

12

The relationship between COVID-19 vaccination attitudes and COVID-19-related parameters with mental health problems: the potential role of behavioral issues.

Mutlu C, Ölmez EB, Yeşilkaya C, Keleş HK, Taşpolat ER, Turan S, Çamlı ŞE. Mutlu C, et al. Clin Exp Vaccine Res. 2026 Jan;15(1):24-34. doi: 10.7774/cevr.2026.15.e4. Epub 2025 Nov 12. Clin Exp Vaccine Res. 2026. PMID: 41660221 Free PMC article.

13

Optimizing vaccine allocation: a review of epidemiological models with behavioral adaptation.

Gudeli R, Mangu K, Agarwal H. Gudeli R, et al. Clin Exp Vaccine Res. 2026 Jan;15(1):9-14. doi: 10.7774/cevr.2026.15.e3. Epub 2025 Nov 6. Clin Exp Vaccine Res. 2026. PMID: 41660220 Free PMC article. Review.

14

Reporting quality and risk of bias in randomized controlled trials of rotavirus vaccines.

Kim J, Cho J. Kim J, et al. Clin Exp Vaccine Res. 2026 Jan;15(1):15-23. doi: 10.7774/cevr.2026.15.e10. Epub 2026 Jan 21. Clin Exp Vaccine Res. 2026. PMID: 41660219 Free PMC article.

15

Temporal dynamics of IgM and IgG after COVID-19 vaccination: a pilot cohort study on breakthrough infections.

Wang J, Li X, Cao Y, Chen X, Reichetzeder C, Hocher B. Wang J, et al. Clin Exp Vaccine Res. 2026 Jan;15(1):63-70. doi: 10.7774/cevr.2026.15.e7. Epub 2025 Dec 31. Clin Exp Vaccine Res. 2026. PMID: 41660218 Free PMC article.

16

Targeting intestinal microbiota with Bifidobacterium breve and Hafnia alvei probiotics does not improve response to influenza vaccine in mice.

Crouzillac C, Onzon M, Unique G, Chambon G, Barnich N, Bourgne N, Billard E. Crouzillac C, et al. Clin Exp Vaccine Res. 2026 Jan;15(1):96-100. doi: 10.7774/cevr.2026.15.e9. Epub 2026 Jan 7. Clin Exp Vaccine Res. 2026. PMID: 41660217 Free PMC article.

17

Knowledge, attitudes and practices towards immunization among adult population in a tertiary care hospital-exploratory survey.

Patlolla N, Yeldandi V, Aralikar S, Sangireddy S, Siddiqua J, Varghese AM, Chandralekha, Sameem MA, Madani, Chaitanya SV, Bai M, Sirisha. Patlolla N, et al. Clin Exp Vaccine Res. 2026 Jan;15(1):88-95. doi: 10.7774/cevr.2026.15.e8. Epub 2026 Jan 6. Clin Exp Vaccine Res. 2026. PMID: 41660216 Free PMC article.

18

Endocrine disorders following SARS-CoV-2 vaccination: a comprehensive systematic review.

Calderon-Hernandez CC, Cahuapaza-Gutierrez NL, Villavicencio-Escudero TV, Ibárcena-Llerena CV, Quiroz-Narvaez C, Coronado-Quispe HY, Chapoñan-Agip NV. Calderon-Hernandez CC, et al. Clin Exp Vaccine Res. 2026 Jan;15(1):35-56. doi: 10.7774/cevr.2026.15.e6. Epub 2025 Nov 27. Clin Exp Vaccine Res. 2026. PMID: 41660215 Free PMC article.

19

Emerging risk of tick-borne diseases in South Korea: Lyme disease, anaplasmosis, and babesiosis.

Oh HS. Oh HS. Clin Exp Vaccine Res. 2026 Jan;15(1):1-8. doi: 10.7774/cevr.2026.15.e5. Epub 2025 Nov 26. Clin Exp Vaccine Res. 2026. PMID: 41660214 Free PMC article. Review.

20

Immunoinformatics and molecular docking reveal potential multi-epitope vaccine against Pseudomonas aeruginosa.

De Leon DO, So AJF, Anupol MVJE, Prieto KTB, Magday MJS, Geronimo ACDC, Bragais EKB. De Leon DO, et al. Clin Exp Vaccine Res. 2026 Jan;15(1):71-87. doi: 10.7774/cevr.2026.15.e2. Epub 2025 Oct 16. Clin Exp Vaccine Res. 2026. PMID: 41660213 Free PMC article.

21

Assessment of determinant factors of willingness to pay for dengue vaccine: multicenter and cross-sectional study in Southeast Sulawesi, Indonesia.

Salam MR, Hasanah Haris RN, Malina R, Pemudi YD. Salam MR, et al. Clin Exp Vaccine Res. 2025 Oct;14(4):375-384. doi: 10.7774/cevr.2025.14.e31. Epub 2025 Jul 2. Clin Exp Vaccine Res. 2025. PMID: 41221179 Free PMC article.

22

Post-authorisation effectiveness and safety study: a multicenter observational study of the effectiveness and safety of the inactivated SARS-CoV-2 vaccine.

Alkaabi N, Mohamed SEDH, Ismail FM, Muwaili AH, Elbakari AS, Khairy LT, Abdelmongy M, Mohammad M, Haider S, Medani WA, Ibrahim M, Faizuddin N, Shakeel TB, Eltantawy I, Ganesan S. Alkaabi N, et al. Clin Exp Vaccine Res. 2025 Oct;14(4):354-365. doi: 10.7774/cevr.2025.14.e37. Epub 2025 Jul 29. Clin Exp Vaccine Res. 2025. PMID: 41221178 Free PMC article.

23

Acute tubulointerstitial nephritis after the second dose of the Pfizer COVID-19 vaccine.

Lendway R, Beneri C, Supe-Markovina K. Lendway R, et al. Clin Exp Vaccine Res. 2025 Oct;14(4):394-398. doi: 10.7774/cevr.2025.14.e33. Epub 2025 Jul 14. Clin Exp Vaccine Res. 2025. PMID: 41221177 Free PMC article.

24

Cytokine responses to respiratory syncytial virus infection in well-differentiated infant nasal epithelial cell cultures.

Yun KW, Chen P, Reynolds SD, Mejias A, Peeples ME, Ramilo O. Yun KW, et al. Clin Exp Vaccine Res. 2025 Oct;14(4):366-374. doi: 10.7774/cevr.2025.14.e30. Epub 2025 Jul 14. Clin Exp Vaccine Res. 2025. PMID: 41221176 Free PMC article.

25

Cholera toxin B subunit fusion enhances the immunogenicity of the H5 stem domain against the H5N2 avian influenza virus.

Lee C, Kim S, You J, Seo M, Kim Y, Park J, Park HW, Rho J. Lee C, et al. Clin Exp Vaccine Res. 2025 Oct;14(4):385-393. doi: 10.7774/cevr.2025.14.e41. Epub 2025 Oct 2. Clin Exp Vaccine Res. 2025. PMID: 41221175 Free PMC article.

26

A narrative review of monkey B virus (Macacine alphaherpesvirus 1): infection, transmission, and post-exposure prophylaxis.

Moon H, Lyoo KS. Moon H, et al. Clin Exp Vaccine Res. 2025 Oct;14(4):335-342. doi: 10.7774/cevr.2025.14.e39. Epub 2025 Sep 24. Clin Exp Vaccine Res. 2025. PMID: 41221174 Free PMC article. Review.

27

Alopecia universalis following human papillomavirus vaccine administration: a case report.

Wu Y, Liu X, Qiao J, Fang H. Wu Y, et al. Clin Exp Vaccine Res. 2025 Oct;14(4):399-401. doi: 10.7774/cevr.2025.14.e36. Epub 2025 Jul 25. Clin Exp Vaccine Res. 2025. PMID: 41221173 Free PMC article.

28

Autoimmune manifestations recorded after SARS-CoV-2 vaccination.

Elghali M, Mhiri M, Chaabane I, Marrakchi W, Kaddoussi R, Maatouk Y, Bellalah A, Changuel M, Jguirim M, Frih-Ayed M, Sakly N. Elghali M, et al. Clin Exp Vaccine Res. 2025 Oct;14(4):343-353. doi: 10.7774/cevr.2025.14.e34. Epub 2025 Jul 21. Clin Exp Vaccine Res. 2025. PMID: 41221172 Free PMC article.

29

Safety and efficacy of maternal RSV vaccination: a systematic review and meta-analysis.

Farag A, Elkholy MKA, Genidy AM, Eltobgy A. Farag A, et al. Clin Exp Vaccine Res. 2025 Oct;14(4):308-324. doi: 10.7774/cevr.2025.14.e35. Epub 2025 Jul 25. Clin Exp Vaccine Res. 2025. PMID: 41221171 Free PMC article. Review.

30

Advancements and challenges in next-generation mRNA vaccine manufacturing systems.

Seo SH, Song MK. Seo SH, et al. Clin Exp Vaccine Res. 2025 Oct;14(4):299-307. doi: 10.7774/cevr.2025.14.e40. Epub 2025 Oct 1. Clin Exp Vaccine Res. 2025. PMID: 41221170 Free PMC article. Review.

31

An updated review of Zika virus vaccine development.

Lee HJ, Abu Bakar S, Shin OS. Lee HJ, et al. Clin Exp Vaccine Res. 2025 Oct;14(4):325-334. doi: 10.7774/cevr.2025.14.e42. Epub 2025 Oct 21. Clin Exp Vaccine Res. 2025. PMID: 41221169 Free PMC article. Review.

32

Evaluation of oral and injectable liposome-based vaccines with synthesized lipid for Japanese encephalitis virus in Sprague-Dawley rats.

Lee H, Woo YM, Lee KW, Jeong YE, Cha JY, Cha JH, Park IG, Lee DG, Lee SH, Xu YQ, Song MH, Kim A. Lee H, et al. Clin Exp Vaccine Res. 2025 Jul;14(3):276-288. doi: 10.7774/cevr.2025.14.e28. Epub 2025 Jun 17. Clin Exp Vaccine Res. 2025. PMID: 40741064 Free PMC article.

33

Identification of conserved CD8+ T cell epitopes in Nipah virus towards vaccine development using an immunoinformatics approach.

Yadao JDT, Alog ACB, Herrera-Ong LR. Yadao JDT, et al. Clin Exp Vaccine Res. 2025 Jul;14(3):229-245. doi: 10.7774/cevr.2025.14.e22. Epub 2025 Apr 14. Clin Exp Vaccine Res. 2025. PMID: 40741063 Free PMC article.

34

Nasal immunization with compound 48/80-adjuvanted acellular pertussis vaccines is an effective strategy to induce pertussis-specific systemic and mucosal immunity.

Church AH, Abraham SN, Staats HF, Johnson-Weaver BT. Church AH, et al. Clin Exp Vaccine Res. 2025 Jul;14(3):246-260. doi: 10.7774/cevr.2025.14.e23. Epub 2025 Apr 15. Clin Exp Vaccine Res. 2025. PMID: 40741062 Free PMC article.

35

A promising Staphylococcus aureus vaccine adjuvant candidate to overcome Staphylococcal infection based on innate immunity.

Mao X, Söderhäll T, Choi GS, Kang JH, Cao C, Yuan Q. Mao X, et al. Clin Exp Vaccine Res. 2025 Jul;14(3):189-202. doi: 10.7774/cevr.2025.14.e27. Epub 2025 Jun 13. Clin Exp Vaccine Res. 2025. PMID: 40741061 Free PMC article. Review.

36

Influenza C virus in humans and animals.

Lee HS, Noh JY, Cheong HJ. Lee HS, et al. Clin Exp Vaccine Res. 2025 Jul;14(3):203-209. doi: 10.7774/cevr.2025.14.e32. Epub 2025 Jul 8. Clin Exp Vaccine Res. 2025. PMID: 40741060 Free PMC article. Review.

37

The effect of COVID-19 vaccination on viral load among health care workers: a retrospective cohort study.

Motamed H, Siami S, Abdan Z, Mozafari F, Khazaei S, Habibi R, Rezaeian S, Heydarpour F. Motamed H, et al. Clin Exp Vaccine Res. 2025 Jul;14(3):261-266. doi: 10.7774/cevr.2025.14.e24. Epub 2025 May 21. Clin Exp Vaccine Res. 2025. PMID: 40741059 Free PMC article.

38

Guillain-Barré syndrome with T-cell receptor gene clonal rearrangement following COVID-19 vaccination: a case report.

Matsumoto K, Morioka T, Tokuda K, Arai S, Matsuo T, Shirasaki R, Ooi J, Tashiro H. Matsumoto K, et al. Clin Exp Vaccine Res. 2025 Jul;14(3):294-297. doi: 10.7774/cevr.2025.14.e26. Epub 2025 Jun 13. Clin Exp Vaccine Res. 2025. PMID: 40741058 Free PMC article.

39

Assessment of naturally acquired IgG antibodies to pneumococcal vaccine serotypes in healthy and type 2 diabetic adults in India.

Shincy MR, Akhila MM, Vandana G, Geetha N, Rajashekaraiah V, Ravikumar KL. Shincy MR, et al. Clin Exp Vaccine Res. 2025 Jul;14(3):267-275. doi: 10.7774/cevr.2025.14.e25. Epub 2025 May 22. Clin Exp Vaccine Res. 2025. PMID: 40741057 Free PMC article.

40

Evaluation of the safety and immunogenicity of the ERAGS-GFP oral rabies vaccine in dogs.

Yang DK, Lee JY, Kim M, Lee HJ, Park GN, Cho YS. Yang DK, et al. Clin Exp Vaccine Res. 2025 Jul;14(3):289-293. doi: 10.7774/cevr.2025.14.e29. Epub 2025 Jun 19. Clin Exp Vaccine Res. 2025. PMID: 40741056 Free PMC article.

41

Multilevel systems biology analysis identifies key immune response profiles and potential correlates of protection for M72/AS01E vaccine against tuberculosis.

Taofeek OO, Alile SO, Evans EM, Ezediuno LO, George IA, Oyewole OM, Owiti PN, Sulaimon LA. Taofeek OO, et al. Clin Exp Vaccine Res. 2025 Jul;14(3):210-228. doi: 10.7774/cevr.2025.14.e21. Epub 2025 Mar 31. Clin Exp Vaccine Res. 2025. PMID: 40741055 Free PMC article.

42

Prophylactic vaccination strategies for adult patients with diabetes: a narrative review of safety profiles and clinical effectiveness.

Walewangko OC, Purnomo JS, Jo PA, Vidian V, Jo J. Walewangko OC, et al. Clin Exp Vaccine Res. 2025 Apr;14(2):101-115. doi: 10.7774/cevr.2025.14.e11. Epub 2025 Mar 18. Clin Exp Vaccine Res. 2025. PMID: 40321796 Free PMC article. Review.

43

Knowledge, attitudes, perceptions and vaccine hesitancy amongst dentists regarding COVID-19 vaccination.

Sultan N, Sharma A, Jafri Z, Sawai MA, Bhardwaj A. Sultan N, et al. Clin Exp Vaccine Res. 2025 Apr;14(2):119-126. doi: 10.7774/cevr.2025.14.e14. Epub 2025 Mar 24. Clin Exp Vaccine Res. 2025. PMID: 40321795 Free PMC article.

44

Study of the effectiveness of combined rabies-tetanus vaccine as compared to individual vaccines.

Ghazy S, Rashed ME, Ali AE, Zedan HH. Ghazy S, et al. Clin Exp Vaccine Res. 2025 Apr;14(2):138-148. doi: 10.7774/cevr.2025.14.e15. Epub 2025 Mar 25. Clin Exp Vaccine Res. 2025. PMID: 40321794 Free PMC article.

45

Maximizing doses from multi-dose vaccine vials using the air bubble trapping technique.

Yang BC, Sanchez KM, Moore KM, Yang ML, Shah NK. Yang BC, et al. Clin Exp Vaccine Res. 2025 Apr;14(2):157-161. doi: 10.7774/cevr.2025.14.e18. Epub 2025 Mar 31. Clin Exp Vaccine Res. 2025. PMID: 40321793 Free PMC article.

46

Protective antibody response in Korean raccoon dogs (Nyctereutes procynoide koreensis) administered a new rabies bait vaccine containing the ERAGS-GFP strain.

Yang DK, Kim CS, Kim J, Yeo J, Yoo S, Won H, Lee JY, Lee HJ, Cho YS. Yang DK, et al. Clin Exp Vaccine Res. 2025 Apr;14(2):149-156. doi: 10.7774/cevr.2025.14.e13. Epub 2025 Mar 24. Clin Exp Vaccine Res. 2025. PMID: 40321792 Free PMC article.

47

Nasopharyngeal carriage and serotype distribution of Streptococcus pneumoniae among HIV-infected children aged >6 years: before and after vaccination of 13-valent pneumococcal conjugate vaccine.

Paramaiswari WT, Muktiarti D, Safari D, Amalia R, Padma M, Winarti Y, Khoeri MM, Daningrat WOD, Tafroji W, Soebandrio A. Paramaiswari WT, et al. Clin Exp Vaccine Res. 2025 Apr;14(2):127-137. doi: 10.7774/cevr.2025.14.e19. Epub 2025 Mar 31. Clin Exp Vaccine Res. 2025. PMID: 40321791 Free PMC article.

48

Minireview: Designing next generation human metapneumovirus (HMPV) vaccine.

Saeed MI. Saeed MI. Clin Exp Vaccine Res. 2025 Apr;14(2):116-118. doi: 10.7774/cevr.2025.14.e12. Epub 2025 Mar 18. Clin Exp Vaccine Res. 2025. PMID: 40321790 Free PMC article. Review.

49

Impact of vitamin D and zinc sufficiency on immune responses following COVID-19 vaccinations among healthcare workers.

Amadi C, Lawson SD, Okafor JC, Agbo E. Amadi C, et al. Clin Exp Vaccine Res. 2025 Apr;14(2):162-168. doi: 10.7774/cevr.2025.14.e17. Epub 2025 Mar 31. Clin Exp Vaccine Res. 2025. PMID: 40321789 Free PMC article.

50

New-onset hematologic disorders following COVID-19 vaccination: a systematic review.

Cahuapaza-Gutierrez NL, Calderon-Hernandez CC, Pajuelo-Vasquez R, Coronado-Quispe HY, Altamirano-Molina M, Runzer-Colmenares FM, Villavicencio-Escudero TV. Cahuapaza-Gutierrez NL, et al. Clin Exp Vaccine Res. 2025 Apr;14(2):169-184. doi: 10.7774/cevr.2025.14.e20. Epub 2025 Apr 8. Clin Exp Vaccine Res. 2025. PMID: 40321788 Free PMC article.

51

Anti-vasospastic mast cell stabilizers: a novel therapeutic approach to anaphylaxis-induced acute coronary syndrome.

Kazama I. Kazama I. Clin Exp Vaccine Res. 2025 Apr;14(2):185-188. doi: 10.7774/cevr.2025.14.e16. Epub 2025 Mar 25. Clin Exp Vaccine Res. 2025. PMID: 40321787 Free PMC article.

52

Root causes of low influenza vaccination coverage rates among nurses working in a tertiary care university hospital in Turkey: result of a study using nominal group technique.

Gürüz RB, Tanriöver MD. Gürüz RB, et al. Clin Exp Vaccine Res. 2025 Jan;14(1):35-43. doi: 10.7774/cevr.2025.14.e6. Epub 2025 Jan 16. Clin Exp Vaccine Res. 2025. PMID: 39927230 Free PMC article.

53

A prospective study on safety and clinical efficacy of rabies biologicals in paediatric patients with category III animal exposure.

Fotedar N, Ravish HS. Fotedar N, et al. Clin Exp Vaccine Res. 2025 Jan;14(1):59-66. doi: 10.7774/cevr.2025.14.e1. Epub 2025 Jan 13. Clin Exp Vaccine Res. 2025. PMID: 39927229 Free PMC article.

54

Enhanced replication of a hepatitis A virus vaccine strain via adaptation in Vero cells.

Seo SH, Choi JA, Kim MS, Yang E, Choi S, Seo DW, Song M. Seo SH, et al. Clin Exp Vaccine Res. 2025 Jan;14(1):10-22. doi: 10.7774/cevr.2025.14.e10. Epub 2025 Jan 22. Clin Exp Vaccine Res. 2025. PMID: 39927228 Free PMC article.

55

Discovery of novel vaccine candidates based on the immunogenic epitopes derived from Toxoplasma membrane proteins.

Hosseini SA, Hashemi S, Siamian D, Asghari A, Fathollahzadeh M, Majidiani H, Shahraki I, Safari MH. Hosseini SA, et al. Clin Exp Vaccine Res. 2025 Jan;14(1):86-100. doi: 10.7774/cevr.2025.14.e4. Epub 2025 Jan 13. Clin Exp Vaccine Res. 2025. PMID: 39927227 Free PMC article.

56

Impact of COVID-19 vaccination on lower urinary tract (LUTS) in benign prostatic hyperplasia (BPH) patients.

Shamshirgaran A, Taheri D, Yahyazadeh SR, Baghdadabad LZ, Zahmatkesh P, Yar EZ, Alaeddini F, Khoshchehreh M, Mohammadi A, Tavoosian A, Aghamir SMK. Shamshirgaran A, et al. Clin Exp Vaccine Res. 2025 Jan;14(1):44-50. doi: 10.7774/cevr.2025.14.e2. Epub 2025 Jan 13. Clin Exp Vaccine Res. 2025. PMID: 39927226 Free PMC article.

57

Immunogenicity and protection of recombinant self-assembling ferritin-hemagglutinin nanoparticle influenza vaccine in mice.

Wang X, Qin Z, Zhang M, Shang B, Li Z, Zhao M, Tang Q, Tang Q, Luo J. Wang X, et al. Clin Exp Vaccine Res. 2025 Jan;14(1):23-34. doi: 10.7774/cevr.2025.14.e7. Epub 2025 Jan 17. Clin Exp Vaccine Res. 2025. PMID: 39927225 Free PMC article.

58

A cross-stack methodology for developing an intelligent vaccination reminder system for children.

Perumal I, Ponnusamy N, Micheal A A, Christy S NL, Muthukumaravel S, Anbalagan N. Perumal I, et al. Clin Exp Vaccine Res. 2025 Jan;14(1):1-9. doi: 10.7774/cevr.2025.14.e5. Epub 2025 Jan 16. Clin Exp Vaccine Res. 2025. PMID: 39927224 Free PMC article. Review.

59

Vaccination status of elite athletes in the German Armed Forces: a retrospective descriptive overview.

Schmitt M, Schröder E, Holtherm C, Lison A, Gerß J, Schulze C. Schmitt M, et al. Clin Exp Vaccine Res. 2025 Jan;14(1):77-85. doi: 10.7774/cevr.2025.14.e8. Epub 2025 Jan 18. Clin Exp Vaccine Res. 2025. PMID: 39927223 Free PMC article.

60

Safety and immunogenicity of an inactivated vero cell-based rabies vaccine (Rabivax-S) in pre-exposure prophylaxis schedule in Vietnam.

Hung PN, Giang LTH, Anh NT, Anh BDT, Pho DC, Van Hung P. Hung PN, et al. Clin Exp Vaccine Res. 2025 Jan;14(1):51-58. doi: 10.7774/cevr.2025.14.e9. Epub 2025 Jan 22. Clin Exp Vaccine Res. 2025. PMID: 39927222 Free PMC article.

61

A comparison between adjuvant and delivering functions of iron oxide and calcium phosphate nanoparticles, using a model protein against Brucella melitensis.

Goudarzi T, Abkar M, Fasihi-Ramandi M, Peikar M, Zamanzadeh Z. Goudarzi T, et al. Clin Exp Vaccine Res. 2025 Jan;14(1):67-76. doi: 10.7774/cevr.2025.14.e3. Epub 2025 Jan 13. Clin Exp Vaccine Res. 2025. PMID: 39927221 Free PMC article.

62

Safety, tolerability, and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine in healthy adults: an open-label randomized phase I clinical trial.

Lim RJ, Qiu X, Leong RN, Gutierrez JL, Halima A, Mostafa M, Ghoneim Y, Abdrabo M, Rashad M, Hannawi S, Liu Y, Mojares Z. Lim RJ, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):315-328. doi: 10.7774/cevr.2024.13.4.315. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525677 Free PMC article.

63

Anti-severe acute respiratory syndrome coronavirus 2 spike receptor-binding domain antibody levels in patients with systemic lupus erythematosus based on vaccination status and related factors in Indonesia.

Hamijoyo L, Philo P, Nathan DS, Tiara MR, Mardiana SR, Susandi E, Ghassani NG, Alisjahbana B. Hamijoyo L, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):348-358. doi: 10.7774/cevr.2024.13.4.348. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525676 Free PMC article.

64

Clinical presentation, associated factors, and course of cutaneous reaction after the booster dose of COVID-19 vaccination.

Jirawattanadon P, Leeyaphan C, Koomanachai P, Pudchakan P, Bunyaratavej S, Kulthanan K, Tuchinda P, Hutachoke T, Nanchaipruek Y, Phumariyapong P. Jirawattanadon P, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):309-314. doi: 10.7774/cevr.2024.13.4.309. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525675 Free PMC article.

65

COVID-19 vaccine hesitancy among medical students, health professionals, and health care workers: an umbrella review.

Iqbal S, Qudah T, Ali I, Abid J, Ahmad AMR. Iqbal S, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):263-270. doi: 10.7774/cevr.2024.13.4.263. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525674 Free PMC article. Review.

66

Protective effects of immunization with a novel 4 recombinant pore-forming toxoid combination vaccine in a rabbit model of systemic methicillin-resistant Staphylococcus aureus infection.

Söderhäll T, Kim SB, Choi GS, Kang KR, Ji JH, Lee BL, Kang JH. Söderhäll T, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):338-347. doi: 10.7774/cevr.2024.13.4.338. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525673 Free PMC article.

67

Safety and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine as a booster against SARS-CoV-2: a phase II, open-label, randomized, double-blinded study.

Lim RJ, Qiu X, Alberto E, Capeding MR, Carlos J, Leong RN, Gutierrez JL, Trillana M, Liu Y, Mojares Z. Lim RJ, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):329-337. doi: 10.7774/cevr.2024.13.4.329. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525672 Free PMC article.

68

Letter to the editor: Evaluating ChatGPT as a tool for educating caregivers on malaria vaccination for children.

Prazeres F. Prazeres F. Clin Exp Vaccine Res. 2024 Oct;13(4):370-371. doi: 10.7774/cevr.2024.13.4.370. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525671 Free PMC article. No abstract available.

69

How does geographical diversity shape vaccine efficacy?

Abavisani M, Ansari B, Ebadpour N, Sahebkar A. Abavisani M, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):271-300. doi: 10.7774/cevr.2024.13.4.271. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525670 Free PMC article. Review.

70

Effect of SpikoGen subunit vaccine administration during pregnancy on fetal development of rats.

Aghsami M, Aljoiber H, Mirfendereski S, Mottaghi-Dastjerdi N, Soltani J, Aslani H, Shariatpanahi M. Aghsami M, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):301-308. doi: 10.7774/cevr.2024.13.4.301. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525669 Free PMC article.

71

Completing the pieces of a puzzle: in-depth probing of Toxoplasma gondii rhoptry protein 4 as a promising target for vaccination using an in-silico approach.

Foroutan M, Shadravan MM. Foroutan M, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):359-369. doi: 10.7774/cevr.2024.13.4.359. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525668 Free PMC article.

72

Incidence of narcolepsy symptoms after taking COVID-19 vaccines: a Jordanian cross-sectional study.

Al Katatbeh M, Al-Mashakbeh Y, Freihat H, Gharam H, Mohammad R, Aldalki R, Eid S, Sharman R, Heissat N, Al-Samarraie G, Al-Shaibie A, Khasawneh L. Al Katatbeh M, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):218-224. doi: 10.7774/cevr.2024.13.3.218. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144130 Free PMC article.

73

Immunogenicity of a novel inactivated canine adenovirus type 2 variant vaccine for dogs.

Yang DK, Ahn S, Lee HJ, Kim M, Kim JT, Lee JY, Cho YS. Yang DK, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):253-258. doi: 10.7774/cevr.2024.13.3.253. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144129 Free PMC article.

74

The BCG vaccine, advantages, and disadvantages of introducing new generation vaccines against Mycobacterium tuberculosis.

Ari MM, Beig M, Sholeh M, Khoshmirsafa M. Ari MM, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):184-201. doi: 10.7774/cevr.2024.13.3.184. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144128 Free PMC article. Review.

75

Insights into structural vaccinology harnessed for universal coronavirus vaccine development.

Lim CP, Leow CH, Lim HT, Kok BH, Chuah C, Oliveira JIN, Jones M, Leow CY. Lim CP, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):202-217. doi: 10.7774/cevr.2024.13.3.202. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144127 Free PMC article. Review.

76

SARS-CoV-2 parental vaccination and risk of multisystem inflammatory syndrome in children: a single-center retrospective study.

Falsaperla R, Sortino V, Collotta AD, Grassi P, Vaccalluzzo MS, Pulvirenti A, Gambilonghi F, Ruggieri M. Falsaperla R, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):225-231. doi: 10.7774/cevr.2024.13.3.225. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144126 Free PMC article.

77

The influence of Omicron on vaccine efficacy and durability: a neurology perspective.

Muruganantham JK, Veerabathiran R. Muruganantham JK, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):175-183. doi: 10.7774/cevr.2024.13.3.175. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144125 Free PMC article. Review.

78

Urinary incontinence after COVID-19 vaccination: a case study in an 8-year-old boy.

Dao TL, Nguyen TK, Nguyen XB, Le KD, Duong KL, Bui DM, Nguyen Le CA, Hoang VT. Dao TL, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):259-262. doi: 10.7774/cevr.2024.13.3.259. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144124 Free PMC article.

79

Intranasal and intraperitoneal immunization against Brucella infection using niosome and mannosylated niosomes containing Brucella recombinant trigger factor/Bp26/Omp31 chimeric protein in a mouse model.

Sharif F, Nazari R, Fasihi-Ramandi M, Taheri RA, Zargar M. Sharif F, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):232-241. doi: 10.7774/cevr.2024.13.3.232. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144123 Free PMC article.

80

Development and validation of enzyme-linked immunosorbent assay for anti-mouse pertussis immunoglobulin G using international reference anti-Bordetella pertussis mouse serum NIBSC 97/642.

Kang KR, Kwon YH, Cho GW, Choi GS, Ji JH, Kang HM, Lee SY, Kang JH. Kang KR, et al. Clin Exp Vaccine Res. 2024 Jul;13(3):242-252. doi: 10.7774/cevr.2024.13.3.242. Epub 2024 Jul 31. Clin Exp Vaccine Res. 2024. PMID: 39144122 Free PMC article.

81

Henoch-Schönlein purpura following mRNA COVID-19 vaccination: a case report.

Lee MO, Yoo SJ. Lee MO, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):166-170. doi: 10.7774/cevr.2024.13.2.166. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752010 Free PMC article.

82

A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of Streptococcus pneumoniae capsular polysaccharide.

Sari RF, Fadilah F, Maladan Y, Sarassari R, Safari D. Sari RF, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):91-104. doi: 10.7774/cevr.2024.13.2.91. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752009 Free PMC article. Review.

83

Inferring B-cell derived T-cell receptor induced multi-epitope-based vaccine candidate against enterovirus 71: a reverse vaccinology approach.

Swain SK, Panda S, Sahu BP, Mahapatra SR, Dey J, Sarangi R, Misra N. Swain SK, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):132-145. doi: 10.7774/cevr.2024.13.2.132. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752008 Free PMC article.

84

A case of alopecia areata after rabies vaccination: unreported adverse effect?

Qiu G, Chen X. Qiu G, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):171-173. doi: 10.7774/cevr.2024.13.2.171. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752007 Free PMC article.

85

Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development.

Oelkrug C. Oelkrug C. Clin Exp Vaccine Res. 2024 Apr;13(2):73-82. doi: 10.7774/cevr.2024.13.2.73. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752006 Free PMC article. Review.

86

Safety assessments of recombinant DTaP vaccines developed in South Korea.

Choi GS, Kang KR, Kim SB, Ji JH, Cho GW, Kang HM, Kang JH. Choi GS, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):155-165. doi: 10.7774/cevr.2024.13.2.155. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752005 Free PMC article.

87

Vaccinomics and adversomics: key elements for a personalized vaccinology.

Laganà A, Visalli G, Di Pietro A, Facciolà A. Laganà A, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):105-120. doi: 10.7774/cevr.2024.13.2.105. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752004 Free PMC article. Review.

88

Efficacy, immunogenicity, and safety of COVID-19 vaccines in individuals with liver cirrhosis: a rapid review and meta-analysis.

Salajegheh F, Rukerd MRZ, Nakhaie M, Ghoreshi ZA, Charostad J, Arefinia N. Salajegheh F, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):83-90. doi: 10.7774/cevr.2024.13.2.83. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752003 Free PMC article. Review.

89

Immunoinformatics studies and design of a novel multi-epitope peptide vaccine against Toxoplasma gondii based on calcium-dependent protein kinases antigens through an in-silico analysis.

Ghaffari AD, Rahimi F. Ghaffari AD, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):146-154. doi: 10.7774/cevr.2024.13.2.146. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752002 Free PMC article.

90

Evaluating the knowledge, attitude, perception, and readiness of caregivers of under 5-year-old children to accept malaria vaccine in Nigeria.

Emmanuel BN, Ishaq AN, Akunne OZ, Saidu UF. Emmanuel BN, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):121-131. doi: 10.7774/cevr.2024.13.2.121. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752001 Free PMC article.

91

Monitoring and evaluation of provincial classical swine fever immunization implementation with an E2 subunit vaccine in Jeju Island, South Korea.

Jang G, Kim EJ, Cho SC, Moon SU, Lee MH, Ko JA, Ko SB, Lee J, Lee C. Jang G, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):54-62. doi: 10.7774/cevr.2024.13.1.54. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362374 Free PMC article.

92

Current development of therapeutic vaccines for the treatment of chronic infectious diseases.

Park PG, Fatima M, An T, Moon YE, Woo S, Youn H, Hong KJ. Park PG, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):21-27. doi: 10.7774/cevr.2024.13.1.21. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362373 Free PMC article. Review.

93

Effectiveness of BBV152 vaccine and ChAdOx1-S vaccine in preventing severe disease among vaccinated patients admitted to a designated COVID-19 hospital in India.

Nivetha R, Anshul R, Sarojini S, Sivagurunathan C, Maikandaan CJ. Nivetha R, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):28-34. doi: 10.7774/cevr.2024.13.1.28. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362372 Free PMC article.

94

Humanized mouse model for vaccine evaluation: an overview.

Kaushik S, Kumari L, Deepak RK. Kaushik S, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):10-20. doi: 10.7774/cevr.2024.13.1.10. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362371 Free PMC article. Review.

95

Acute interstitial nephritis with acute kidney injury after COVID-19 vaccination: a case report.

Lim J, Paek JH, Shin HC, Park WY, Jin K, Choe M, Han S, Kim Y. Lim J, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):68-71. doi: 10.7774/cevr.2024.13.1.68. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362370 Free PMC article.

96

Comparative analysis of antibody responses to BNT162b2, ChAdOx1, and CoronaVac vaccines in the Albanian population over the pandemic years 2021 to 2022.

Sulcebe G, Kurti-Prifti M, Shyti E, Dashi-Pasholli J, Cenko F, Ylli A. Sulcebe G, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):63-67. doi: 10.7774/cevr.2024.13.1.63. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362369 Free PMC article.

97

Acute abdomen following COVID-19 vaccination: a systematic review.

Cahuapaza-Gutierrez NL, Pajuelo-Vasquez R, Quiroz-Narvaez C, Rioja-Torres F, Quispe-Andahua M, Runzer-Colmenares FM. Cahuapaza-Gutierrez NL, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):42-53. doi: 10.7774/cevr.2024.13.1.42. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362368 Free PMC article.

98

Immune modulation and possible pathological implications mediated by naturally produced immunoglobulin G idiotypes: from historical to recent experimental and clinical studies focused on atopic dermatitis.

Santander L, Machado NR, Fagundes BO, Victor JR. Santander L, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):1-9. doi: 10.7774/cevr.2024.13.1.1. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362367 Free PMC article. Review.

99

Safety and immunogenicity of different booster vaccination schemes for COVID-19 used in El Salvador.

Sandoval X, Domínguez R, Recinos D, Zelaya S, Cativo P, Docena GH. Sandoval X, et al. Clin Exp Vaccine Res. 2024 Jan;13(1):35-41. doi: 10.7774/cevr.2024.13.1.35. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362366 Free PMC article.

100

Impact of COVID-19 pandemic on routine immunization services in a tertiary care hospital of Rajasthan, India.

Dhamania M, Gaur K. Dhamania M, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):313-318. doi: 10.7774/cevr.2023.12.4.313. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025919 Free PMC article.

101

Impact of the COVID-19 vaccine booster strategy on vaccine protection: a pilot study of a military hospital in Taiwan.

Wang YL, Cheng ST, Shen CF, Huang SW, Cheng CM. Wang YL, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):337-345. doi: 10.7774/cevr.2023.12.4.337. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025918 Free PMC article.

102

Lassa fever vaccine prospects: identifying immunodominant multi-epitopes as vaccine candidate.

Nwabueze CO. Nwabueze CO. Clin Exp Vaccine Res. 2023 Oct;12(4):346-347. doi: 10.7774/cevr.2023.12.4.346. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025917 Free PMC article. No abstract available.

103

Comparison of media for a human peripheral blood mononuclear cell-based in vitro vaccine evaluation system.

Gong S, Fajar P, De Vries-Idema J, Huckriede A. Gong S, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):328-336. doi: 10.7774/cevr.2023.12.4.328. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025916 Free PMC article.

104

Serological response 5 months after the BNT162b2 COVID-19 vaccination in patients with various hematological disorders in Japan.

Marumo Y, Yoshida T, Furukawa Y, Ina K, Kamiya A, Kataoka T, Kayukawa S. Marumo Y, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):319-327. doi: 10.7774/cevr.2023.12.4.319. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025915 Free PMC article.

105

COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review.

Suhaimi SNAA, Zaki IAH, Noordin ZM, Hussin NSM, Ming LC, Zulkifly HH. Suhaimi SNAA, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):265-290. doi: 10.7774/cevr.2023.12.4.265. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025914 Free PMC article. Review.

106

Immunization of mice with chimeric protein-loaded aluminum hydroxide and selenium nanoparticles induces reduction of Brucella melitensis infection in mice.

Goudarzi T, Abkar M, Zamanzadeh Z, Fasihi-Ramandi M. Goudarzi T, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):304-312. doi: 10.7774/cevr.2023.12.4.304. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025913 Free PMC article.

107

Barriers to measles mumps rubella vaccine acceptance in the three southern border provinces of Thailand.

Sirithammaphan U, Chaisang U, Pongrattanamarn K. Sirithammaphan U, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):298-303. doi: 10.7774/cevr.2023.12.4.298. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025912 Free PMC article.

108

Experimental animal models for development of human enterovirus vaccine.

Song JM. Song JM. Clin Exp Vaccine Res. 2023 Oct;12(4):291-297. doi: 10.7774/cevr.2023.12.4.291. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025911 Free PMC article. Review.

109

Factors associated with parental intention to vaccinate their preschool children against COVID-19: a cross-sectional survey in urban area of Jakarta, Indonesia.

Santi T, Hegar B, Munasir Z, Prayitno A, Werdhani RA, Bandar INS, Jo J, Uswa R, Widia R, Vandenplas Y. Santi T, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):240-248. doi: 10.7774/cevr.2023.12.3.240. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599811 Free PMC article.

110

Vaccine hesitancy: acceptance of COVID-19 vaccine in Pakistan.

Qazi SH, Masoud S, Usmani MA. Qazi SH, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):209-215. doi: 10.7774/cevr.2023.12.3.209. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599810 Free PMC article.

111

Exploring the essential need for developing COVID-19 vaccines in the Philippines.

Cordero DA Jr. Cordero DA Jr. Clin Exp Vaccine Res. 2023 Jul;12(3):260-261. doi: 10.7774/cevr.2023.12.3.260. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599809 Free PMC article. No abstract available.

112

Is SARS-CoV-2 vaccination related Guillain-Barré syndrome really different from that due to other causes?

Finsterer J. Finsterer J. Clin Exp Vaccine Res. 2023 Jul;12(3):262-263. doi: 10.7774/cevr.2023.12.3.262. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599808 Free PMC article. No abstract available.

113

The issue of vaccine refusal: the study of a risky behavior.

Osadchuk M, Tikhonova Y, Krivetskaya M. Osadchuk M, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):216-223. doi: 10.7774/cevr.2023.12.3.216. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599807 Free PMC article.

114

Antibody response to COVID-19 vaccination in patients on chronic hemodialysis.

Choi H, Han S, Kim JS, Park B, Lee MJ, Shin GT, Kim H, Kim K, Park AY, Shin HJ, Park I. Choi H, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):249-259. doi: 10.7774/cevr.2023.12.3.249. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599806 Free PMC article.

115

Anti-SARS-CoV-2 receptor binding domain antibodies after the second dose of Sinovac and AstraZeneca vaccination.

Gondokesumo ME, Purnamayanti A, Hanum PS, Santosa WN, Wardhana AP, Avanti C. Gondokesumo ME, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):224-231. doi: 10.7774/cevr.2023.12.3.224. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599805 Free PMC article.

116

Vaccines development in India: advances, regulation, and challenges.

Salalli R, Dange JR, Dhiman S, Sharma T. Salalli R, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):193-208. doi: 10.7774/cevr.2023.12.3.193. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599804 Free PMC article. Review.

117

Perspective vaccines for emerging viral diseases in farm animals.

Allam AM, Elbayoumy MK, Ghazy AA. Allam AM, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):179-192. doi: 10.7774/cevr.2023.12.3.179. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599803 Free PMC article. Review.

118

Immunogenic characterization of AlPO₄ adsorbed Td vaccine and liposome-mediated Td vaccine.

Shuhsadhe R, Vazhayil J, Ali HS, Orsud H, Mergani AEO. Shuhsadhe R, et al. Clin Exp Vaccine Res. 2023 Jul;12(3):232-239. doi: 10.7774/cevr.2023.12.3.232. Epub 2023 Jul 31. Clin Exp Vaccine Res. 2023. PMID: 37599802 Free PMC article.

119

Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies.

Thookhamme C, Navinpipat M, Sasakul A, Pattarakosol P, Lertchaisataporn K, Tawinprai K, Praditsuktavorn P. Thookhamme C, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):107-115. doi: 10.7774/cevr.2023.12.2.107. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214149 Free PMC article.

120

Detection of immunity in sheep following anti-rabies vaccination.

Rathnadiwakara H, Gunatilake M, Cliquet F, Wasniewski M, Thammitiyagodage M, Karunakaran R, Thibault JC, Ijas M. Rathnadiwakara H, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):97-106. doi: 10.7774/cevr.2023.12.2.97. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214148 Free PMC article.

121

Nondaily dosing schedule of allergen-specific sublingual immunotherapy: efficacy and safety.

Abdelwahab HW, Abd El-Maksoud A. Abdelwahab HW, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):121-126. doi: 10.7774/cevr.2023.12.2.121. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214147 Free PMC article.

122

Occurrence of erythema multiforme following COVID-19 vaccination: a review.

Yousefian M, Khadivi A. Yousefian M, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):87-96. doi: 10.7774/cevr.2023.12.2.87. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214146 Free PMC article. Review.

123

Pregnant women's knowledge about and beliefs toward COVID-19 vaccine: a cross-sectional study.

Gunkaya OS, Tekin AB, Yassa M, Arslan O, Karakoç K, Demirtaş N, Usta C, Künt İşgüder Ç, Tuğ N. Gunkaya OS, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):134-142. doi: 10.7774/cevr.2023.12.2.134. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214145 Free PMC article.

124

Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers.

Mochizuki T, Hori T, Yano K, Ikari K, Okazaki K. Mochizuki T, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):116-120. doi: 10.7774/cevr.2023.12.2.116. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214144 Free PMC article.

125

Strategic construction of mRNA vaccine derived from conserved and experimentally validated epitopes of avian influenza type A virus: a reverse vaccinology approach.

Herrera-Ong LR. Herrera-Ong LR. Clin Exp Vaccine Res. 2023 Apr;12(2):156-171. doi: 10.7774/cevr.2023.12.2.156. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214143 Free PMC article.

126

Exploring the underlying factors of COVID-19 vaccination hesitancy in Ahvaz, Iran: a comprehensive cross-sectional study.

Afshari P, Alavi SM, Abedi P, Beheshtinasab M, Dashtpayma S, Amiri H. Afshari P, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):127-133. doi: 10.7774/cevr.2023.12.2.127. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214142 Free PMC article.

127

Disseminated life-threatening viral skin rash in a child with atopic dermatitis.

Herzum A, Occella C, Garibeh E, Gariazzo L, Viglizzo G. Herzum A, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):176-178. doi: 10.7774/cevr.2023.12.2.176. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214141 Free PMC article.

128

Guillain-Barré syndrome associated with SARS-CoV-2 vaccination: how is it different? a systematic review and individual participant data meta-analysis.

Reddy YM, Murthy JM, Osman S, Jaiswal SK, Gattu AK, Pidaparthi L, Boorgu SK, Chavan R, Ramakrishnan B, Yeduguri SR. Reddy YM, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):143-155. doi: 10.7774/cevr.2023.12.2.143. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214140 Free PMC article.

129

A case report overlapped vaccine and COVID-19 in disseminated atherosclerosis.

Bayrak V. Bayrak V. Clin Exp Vaccine Res. 2023 Apr;12(2):172-175. doi: 10.7774/cevr.2023.12.2.172. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214139 Free PMC article.

130

Individual expression and processing of hepatitis C virus E1/E2 epitopes-based DNA vaccine candidate in healthy humans' peripheral blood mononuclear cells.

Nadeem R, Maghraby AS, Abd-Elshafy DN, Barakat AB, Bahgat MM. Nadeem R, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):47-59. doi: 10.7774/cevr.2023.12.1.47. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844691 Free PMC article.

131

Comparative evaluation of gold nanoparticles and Alum as immune enhancers against rabies vaccine and related immune reactivity, physiological, and histopathological alterations: in vivo study.

El-Hennamy REE, Mahmoud SM, El-Yamany NA, Hassanein HH, Amer ME, Mohamed AF. El-Hennamy REE, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):32-46. doi: 10.7774/cevr.2023.12.1.32. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844690 Free PMC article.

132

Herpes zoster ophthalmicus after COVID-19 vaccine booster in healthy younger adult: a case report.

Awaly ZWN. Awaly ZWN. Clin Exp Vaccine Res. 2023 Jan;12(1):82-84. doi: 10.7774/cevr.2023.12.1.82. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844689 Free PMC article.

133

Adverse events following immunisation with the first dose of sputnik V among Iranian health care providers.

Jafarzadeh Esfehani R, Zahmatkesh M, Goldozian R, Farkhonde J, Jaripour E, Hatami A, Bidkhori HR, Shamsian SK, Shamsian SA, Mojahedi F. Jafarzadeh Esfehani R, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):25-31. doi: 10.7774/cevr.2023.12.1.25. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844688 Free PMC article.

134

Exploring the experience of developing COVID-19 vaccines in Iran.

Ghanei M, Mohabattalab A, Fartash K, Kolahchi N, Khakdaman A, Kaghazian H, Bagheri A. Ghanei M, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):1-12. doi: 10.7774/cevr.2023.12.1.1. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844687 Free PMC article. Review.

135

Before blaming SARS-CoV-2 vaccines for thalamic lacunar stroke, alternative etiologies must be ruled out.

Finsterer J. Finsterer J. Clin Exp Vaccine Res. 2023 Jan;12(1):85-86. doi: 10.7774/cevr.2023.12.1.85. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844686 Free PMC article. No abstract available.

136

Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions.

Klingel H, Krüttgen A, Imöhl M, Kleines M. Klingel H, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):60-69. doi: 10.7774/cevr.2023.12.1.60. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844685 Free PMC article.

137

New typhoid vaccine using sponge-like reduced protocol: development and evaluation.

Bahy R, Gaber A, Zedan H, Mabrook M. Bahy R, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):70-76. doi: 10.7774/cevr.2023.12.1.70. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844684 Free PMC article.

138

The threat of Monkeypox in the Philippines: another problematic preparation and management for the healthcare system?

Cordero DA Jr. Cordero DA Jr. Clin Exp Vaccine Res. 2023 Jan;12(1):77-79. doi: 10.7774/cevr.2023.12.1.77. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844683 Free PMC article.

139

Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic review and meta-analysis.

Iryaningrum MR, Cahyadi A, Damara FA, Bandiara R, Marbun MBH. Iryaningrum MR, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):13-24. doi: 10.7774/cevr.2023.12.1.13. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844682 Free PMC article. Review.

140

Psoriasis flares after COVID-19 vaccination: adherence to biologic therapy reduces psoriasis exacerbations: a case-control study.

Burlando M, Herzum A, Cozzani E, Parodi A. Burlando M, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):80-81. doi: 10.7774/cevr.2023.12.1.80. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844681 Free PMC article.

141

Deep vein thrombosis and acute hepatitis after ChAdOx1 nCov-19 vaccination in a Charcot-Marie-Tooth patient: a case report.

Napoli R, Visonà E. Napoli R, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):294-297. doi: 10.7774/cevr.2022.11.3.294. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451672 Free PMC article.

142

Livedo reticularis following administration of ChAdOx1 nCoV-19 vaccine (AZD1222): a report of two cases.

Kim JH, Uh JA, Kim HS, Lee SK, Kim MS, Lee UH. Kim JH, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):298-301. doi: 10.7774/cevr.2022.11.3.298. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451671 Free PMC article.

143

Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever.

Rowaiye AB, Nwonu EJ, Asala TM, Ogu AC, Bur D, Chukwu C, Oli AN, Agbalalah T. Rowaiye AB, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):249-263. doi: 10.7774/cevr.2022.11.3.249. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451670 Free PMC article.

144

Factors associated with intention to take COVID-19 vaccine among the university students in Bangladesh.

Shuvo NA, Mondal MSH. Shuvo NA, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):274-284. doi: 10.7774/cevr.2022.11.3.274. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451669 Free PMC article.

145

Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants.

Anggraeni R, Ana ID, Wihadmadyatami H. Anggraeni R, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):235-248. doi: 10.7774/cevr.2022.11.3.235. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451668 Free PMC article. Review.

146

Field evaluation of the safety and immunogenicity of a classical swine fever virus E2 subunit vaccine in breeding and nursery animals on Jeju Island, South Korea.

Jang G, Kim EJ, Cho SC, Moon SU, Kim BS, Kim J, Jeong KJ, Song K, Mun SH, Kang WM, Lee J, Park C, Yang HS, Lee C. Jang G, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):264-273. doi: 10.7774/cevr.2022.11.3.264. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451667 Free PMC article.

147

COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production.

Adeyemi O. Adeyemi O. Clin Exp Vaccine Res. 2022 Sep;11(3):302-303. doi: 10.7774/cevr.2022.11.3.302. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451666 Free PMC article. No abstract available.

148

Quick drop of platelet counts in children with chronic immune thrombocytopenia after COVID-19 mRNA vaccination: case reports.

Lassandro G, Carriero F, Palladino V, Del Vecchio GC, Giordano P. Lassandro G, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):290-293. doi: 10.7774/cevr.2022.11.3.290. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451665 Free PMC article.

149

Recombinant proteins of spike protein of SARS-CoV-2 with the Omicron receptor-binding domain induce production of highly Omicron-specific neutralizing antibodies.

Kang H, Kim D, Min K, Park M, Kim SH, Sohn EJ, Choi BH, Hwang I. Kang H, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):285-289. doi: 10.7774/cevr.2022.11.3.285. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451664 Free PMC article.

150

Unmasking the COVID-19 vaccination myths: intervention through collaboration.

Cordero DA Jr. Cordero DA Jr. Clin Exp Vaccine Res. 2022 Sep;11(3):304-305. doi: 10.7774/cevr.2022.11.3.304. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451663 Free PMC article. No abstract available.

151

Exploring the myths surrounding the COVID-19 vaccines in Africa: the study to investigate their impacts on acceptance using online survey and social media.

Lamptey E, Senkyire EK, Dorcas S, Benita DA, Boakye EO, Ikome T, Asamoah A. Lamptey E, et al. Clin Exp Vaccine Res. 2022 May;11(2):193-208. doi: 10.7774/cevr.2022.11.2.193. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799880 Free PMC article.

152

Evaluation of precipitation time of the aluminum salts adsorbed potentially frozen vaccines used in the Polish National Immunization Schedule for their pre-qualification before the administration.

Górska P, Główka M, Woźnica K, Zasada AA. Górska P, et al. Clin Exp Vaccine Res. 2022 May;11(2):155-162. doi: 10.7774/cevr.2022.11.2.155. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799879 Free PMC article.

153

COVID-19 vaccination policies and the new challenges of international travel.

Ramírez C, Choi JN, Durón RM. Ramírez C, et al. Clin Exp Vaccine Res. 2022 May;11(2):230-232. doi: 10.7774/cevr.2022.11.2.230. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799878 Free PMC article. No abstract available.

154

Thalamic hemi-chorea: a rare complication after receiving the adenoviral vector-based COVID-19 vaccine: a case report.

Shahali H, Farahani RH, Asgari A, Hazrati E. Shahali H, et al. Clin Exp Vaccine Res. 2022 May;11(2):217-221. doi: 10.7774/cevr.2022.11.2.217. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799877 Free PMC article.

155

SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants.

Syahniar R, Kharisma DS. Syahniar R, et al. Clin Exp Vaccine Res. 2022 May;11(2):173-183. doi: 10.7774/cevr.2022.11.2.173. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799876 Free PMC article. Review.

156

Adult vaccine-related knowledge, attitudes, and behaviors in Turkey.

Karaoğlu SA, Taş BG, Toprak D. Karaoğlu SA, et al. Clin Exp Vaccine Res. 2022 May;11(2):133-140. doi: 10.7774/cevr.2022.11.2.133. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799875 Free PMC article.

157

Exploring interventions against COVID-19 vaccine hesitancy in the Philippines.

Cordero DA Jr. Cordero DA Jr. Clin Exp Vaccine Res. 2022 May;11(2):233-234. doi: 10.7774/cevr.2022.11.2.233. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799874 Free PMC article. No abstract available.

158

A survey of healthcare workers' recommendations about human papillomavirus vaccination.

Nishioka H, Onishi T, Kitano T, Takeyama M, Imakita N, Kasahara K, Kawaguchi R, Masaki JA, Nogami K. Nishioka H, et al. Clin Exp Vaccine Res. 2022 May;11(2):149-154. doi: 10.7774/cevr.2022.11.2.149. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799873 Free PMC article.

159

Subacute thyroiditis after receiving the vaccine for COVID-19: a case report and literature review.

Vu TB, Chu DT, Le DT, Hoang TTD, Gautret P, Hoang VT. Vu TB, et al. Clin Exp Vaccine Res. 2022 May;11(2):226-229. doi: 10.7774/cevr.2022.11.2.226. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799872 Free PMC article.

160

Epstein-Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report.

Herzum A, Trave I, D'Agostino F, Burlando M, Cozzani E, Parodi A. Herzum A, et al. Clin Exp Vaccine Res. 2022 May;11(2):222-225. doi: 10.7774/cevr.2022.11.2.222. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799871 Free PMC article.

161

Heterologous prime-boost with the mRNA-1273 vaccine among CoronaVac-vaccinated healthcare workers in Indonesia.

Santi T, Sungono V, Kamarga L, Samakto B, Hidayat F, Hidayat FK, Satolom M, Permana A, Yusuf I, Suriapranata IM, Jo J. Santi T, et al. Clin Exp Vaccine Res. 2022 May;11(2):209-216. doi: 10.7774/cevr.2022.11.2.209. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799870 Free PMC article.

162

Nasal vaccine as a booster shot: a viable solution to restrict pandemic?

Meenakshi S, Kumar VU, Dhingra S, Murti K. Meenakshi S, et al. Clin Exp Vaccine Res. 2022 May;11(2):184-192. doi: 10.7774/cevr.2022.11.2.184. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799869 Free PMC article. Review.

163

Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas.

Mazumder S, Swank V, Dvorina N, Johnson JM, Tuohy VK. Mazumder S, et al. Clin Exp Vaccine Res. 2022 May;11(2):163-172. doi: 10.7774/cevr.2022.11.2.163. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799868 Free PMC article.

164

Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study.

Utami TW, Andrijono A, Putra A, Indarti J, Fleuren G, Jordanova E, Humairah I, Utomo A. Utami TW, et al. Clin Exp Vaccine Res. 2022 May;11(2):141-148. doi: 10.7774/cevr.2022.11.2.141. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799867 Free PMC article.

165

Alopecia areata after COVID-19 vaccination.

Gallo G, Mastorino L, Tonella L, Ribero S, Quaglino P. Gallo G, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):129-132. doi: 10.7774/cevr.2022.11.1.129. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223675 Free PMC article.

166

The risk of confusion between AstraZeneka COVID-19 vaccine side effects and signs of COVID-19 infection: a case report.

Nomali M, Afzali M. Nomali M, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):125-128. doi: 10.7774/cevr.2022.11.1.125. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223674 Free PMC article.

167

Severity of adverse reactions is associated with T-cell response in mRNA-1273 vaccinated health care workers.

Klingel H, Lauen M, Krüttgen A, Imöhl M, Kleines M. Klingel H, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):121-124. doi: 10.7774/cevr.2022.11.1.121. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223673 Free PMC article.

168

Assessment on anti-SARS-CoV-2 receptor-binding domain antibodies among CoronaVac-vaccinated Indonesian adults.

Jo J, Sanjaya A, Pinontoan R, Aruan M, Wahyuni RM, Viktaria V. Jo J, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):116-120. doi: 10.7774/cevr.2022.11.1.116. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223672 Free PMC article.

169

Reactogenicity to COVID-19 vaccination in the United States of America.

Sanyaolu A, Marinkovic A, Prakash S, Desai P, Haider N, Abbasi AF, Mehraban N, Jain I, Ekeh A, Shazley O, Okorie C, Orish VN. Sanyaolu A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):104-115. doi: 10.7774/cevr.2022.11.1.104. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223671 Free PMC article.

170

Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers.

Krüttgen A, Haase G, Haefner H, Imöhl M, Kleines M. Krüttgen A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):96-103. doi: 10.7774/cevr.2022.11.1.96. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223670 Free PMC article.

171

Factors associated with side effects of COVID-19 vaccine in Indonesia.

Wibowo J, Heriyanto RS, Wijovi F, Halim DA, Claudia C, Marcella E, Susanto B, Indrawan M, Heryadi NK, Imanuelly M, Anurantha JJ, Hariyanto TI, Marcellin C, Sinaga TD, Rizki SA, Sieto N, Siregar JI, Lugito NPH, Kurniawan A. Wibowo J, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):89-95. doi: 10.7774/cevr.2022.11.1.89. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223669 Free PMC article.

172

COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production.

Lamptey E, Senkyire EK, Benita DA, Boakye EO. Lamptey E, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):82-88. doi: 10.7774/cevr.2022.11.1.82. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223668 Free PMC article. Review.

173

Successful seroconversion against diphtheria and tetanus induced through maternal vaccination in a region of Colombia.

Hincapie-Palacio D, Echeverri A, Hoyos C, Vargas-Restrepo F, Ospina M, Buitrago S, Ochoa J. Hincapie-Palacio D, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):72-81. doi: 10.7774/cevr.2022.11.1.72. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223667 Free PMC article.

174

Knowledge, attitude, and practices regarding human papillomavirus and its' vaccination among the young medical professionals and students of Bangladesh.

Chowdhury S, Ara R, Roy S, Tanvir SMS, Eva FN, Neela TM, Moonmoon AA, Sifat S, Zamila M, Hawlader MDH. Chowdhury S, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):63-71. doi: 10.7774/cevr.2022.11.1.63. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223666 Free PMC article.

175

Protection against virulent Brucella spp. by gamma-irradiated B. ovis in BALB/c mice model.

Al-Mariri A, Al-Hallab L, Alabras R, Kherbik H, Khawajkiah M. Al-Mariri A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):53-62. doi: 10.7774/cevr.2022.11.1.53. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223665 Free PMC article.

176

Protectivity and safety following recombinant hepatitis B vaccine with different source of bulk compared to hepatitis B (Bio Farma) vaccine in Indonesia.

Nency YM, Rahmadi FA, Mulyono, Anantyo DT, Farhanah N, Hapsari R, Farida H, Sadhana U, Djagat H, Kristina TN, Juniarto AZ, Puspita M, Sari RM, Bachtiar NS. Nency YM, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):43-52. doi: 10.7774/cevr.2022.11.1.43. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223664 Free PMC article.

177

Preparation and field study of combined vaccine against Clostridium perfringens type A and bovine viral diarrhea virus in camels.

Elhelw HA, El Fadeel MRA, El-Sergany E, Allam A, Elbayoumy MK, El-Kattan AM, El-Kholy AA. Elhelw HA, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):30-42. doi: 10.7774/cevr.2022.11.1.30. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223663 Free PMC article.

178

Expression of full and fragment-B of diphtheria toxin genes in Escherichia coli for generating of recombinant diphtheria vaccines.

Abulmagd S, Khattab AEA, Zedan H. Abulmagd S, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):12-29. doi: 10.7774/cevr.2022.11.1.12. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223662 Free PMC article.

179

Comparison and efficacy of two different sheep pox vaccines prepared from the Bakırköy strain against lumpy skin disease in cattle.

Uzar S, Sarac F, Gulyaz V, Enul H, Yılmaz H, Turan N. Uzar S, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):1-11. doi: 10.7774/cevr.2022.11.1.1. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223661 Free PMC article.

180

Are the COVID-19's vaccines efficient on the most dangerous variant of SARS-CoV-2?

Davoodi P, Hashemi A. Davoodi P, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):301-303. doi: 10.7774/cevr.2021.10.3.301. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703817 Free PMC article. No abstract available.

181

Acute urticarial rash after COVID-19 vaccination containing Polysorbate 80.

Burlando M, Herzum A, Cozzani E, Parodi A. Burlando M, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):298-300. doi: 10.7774/cevr.2021.10.3.298. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703816 Free PMC article.

182

A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?

Barsha SY, Akiful Haque MM, Rashid MU, Rahman ML, Hossain MA, Zaman S, Bhuiyan E, Sultana R, Hossian M, Nabi MH, Hawlader MDH. Barsha SY, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):293-297. doi: 10.7774/cevr.2021.10.3.293. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703815 Free PMC article.

183

Shingles and mRNA COVID-19 vaccine.

Mungmunpuntipantip R, Wiwanitkit V. Mungmunpuntipantip R, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):292. doi: 10.7774/cevr.2021.10.3.292. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703814 Free PMC article. No abstract available.

184

Challenges managing COVID vaccine-induced immune thrombotic thrombocytopenia in low-middle income countries.

Ramírez C, Hernández RJS, Durón RM. Ramírez C, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):290-291. doi: 10.7774/cevr.2021.10.3.290. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703813 Free PMC article. No abstract available.

185

Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center study.

Kang YM, Lim J, Choe KW, Lee KD, Jo DH, Kim MJ, Kim JM, Kim KN. Kang YM, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):282-289. doi: 10.7774/cevr.2021.10.3.282. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703812 Free PMC article.

186

Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population.

Khanum I, Kumar L, Awan S, Jamil B. Khanum I, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):276-281. doi: 10.7774/cevr.2021.10.3.276. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703811 Free PMC article.

187

Post-vaccination COVID-19 deaths: a review of available evidence and recommendations for the global population.

Lamptey E. Lamptey E. Clin Exp Vaccine Res. 2021 Sep;10(3):264-275. doi: 10.7774/cevr.2021.10.3.264. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703810 Free PMC article. Review.

188

The effect of apolipoprotein A-I and perfluorocarbon emulsion on the production of specific antibodies in mice.

Zhalimov V, Gritsyna Y, Morenkov O. Zhalimov V, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):259-263. doi: 10.7774/cevr.2021.10.3.259. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703809 Free PMC article.

189

Evaluation of the antigenic stability of influenza virus like particles after exposure to acidic or basic pH.

Kim SH, Park YC, Song JM. Kim SH, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):252-258. doi: 10.7774/cevr.2021.10.3.252. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703808 Free PMC article.

190

Transient expression of fusion and hemagglutinin-neuraminidase epitopes of Newcastle disease virus in maize as a potent candidate vaccine.

Shahriari AG, Niazi A, Habibi-Pirkoohi M. Shahriari AG, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):245-251. doi: 10.7774/cevr.2021.10.3.245. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703807 Free PMC article.

191

Vaccine usage and wastage in a designated Yellow Fever Vaccination Centre in North India.

Dkhar SA, Quansar R, Haq I, Khan SMS. Dkhar SA, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):240-244. doi: 10.7774/cevr.2021.10.3.240. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703806 Free PMC article.

192

Staphylococcus aureus derived hyaluronic acid and bacillus Calmette-Guérin purified proteins as immune enhancers to rabies vaccine and related immuno-histopathological alterations.

Shebl RI, Amer ME, Abuamara TMM, Matar ER, Ahmed HF, Gomah TA, El Moselhy LE, Abu-Elghait M, Mohamed AF. Shebl RI, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):229-239. doi: 10.7774/cevr.2021.10.3.229. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703805 Free PMC article.

193

Oral immunization of rat with chromosomal expression LipL32 in attenuated Salmonella vaccine induces immune respond against pathogenic Leptospira.

Samakchan N, Thinwang P, Boonyom R. Samakchan N, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):217-228. doi: 10.7774/cevr.2021.10.3.217. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703804 Free PMC article.

194

Adverse events following pediatric immunization in an Indian city.

Paramkusham V, Palakurthy P, Gurram NS, Talla V, Vishwas HN, Jupally VR, Pattnaik S. Paramkusham V, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):211-216. doi: 10.7774/cevr.2021.10.3.211. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703803 Free PMC article.

195

Parenteral, non-live rotavirus vaccine: recent history and future perspective.

Song JM. Song JM. Clin Exp Vaccine Res. 2021 Sep;10(3):203-210. doi: 10.7774/cevr.2021.10.3.203. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703802 Free PMC article. Review.

196

A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?

Aksu SB, Öztürk GZ. Aksu SB, et al. Clin Exp Vaccine Res. 2021 May;10(2):198-201. doi: 10.7774/cevr.2021.10.2.198. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222134 Free PMC article.

197

Acute myocarditis associated with anti-COVID-19 vaccination.

Nevet A. Nevet A. Clin Exp Vaccine Res. 2021 May;10(2):196-197. doi: 10.7774/cevr.2021.10.2.196. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222133 Free PMC article.

198

A possible protective role for Bacillus Calmette-Guérin therapy in urinary bladder cancer in the era of COVID-19: a brief report.

Ohadian Moghadam S, Abbasi B, Nowroozi A, Amini E, Nowroozi MR, Momeni SA, Niroomand H. Ohadian Moghadam S, et al. Clin Exp Vaccine Res. 2021 May;10(2):191-195. doi: 10.7774/cevr.2021.10.2.191. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222132 Free PMC article.

199

A nationwide survey of the potential acceptance and determinants of COVID-19 vaccines in Ghana.

Lamptey E, Serwaa D, Appiah AB. Lamptey E, et al. Clin Exp Vaccine Res. 2021 May;10(2):183-190. doi: 10.7774/cevr.2021.10.2.183. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222131 Free PMC article.

200

Determinants of the willingness of the general population to get vaccinated against COVID-19 in a developing country.

Al-Mistarehi AH, Kheirallah KA, Yassin A, Alomari S, Aledrisi MK, Bani Ata EM, Hammad NH, Khanfar AN, Ibnian AM, Khassawneh BY. Al-Mistarehi AH, et al. Clin Exp Vaccine Res. 2021 May;10(2):171-182. doi: 10.7774/cevr.2021.10.2.171. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222130 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

415 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

415 results

Results by year